GSK
GlaxoSmithKline PLC
50.50$
+0.3%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.66 | 1.31 | 3.31 | 3.50 | 4.24 | 4.00 | 4.19 | 4.91 | 3.63 | 3.84 | 3.16 | 3.47 | |
| 1.04 | 0.95 | 0.95 | 1.51 | 0.89 | 1.49 | 0.31 | 1.56 | 1.13 | 1.39 | 1.23 | 1.80 | |
| 0.17 | 0.19 | 0.16 | 0.17 | 0.18 | 0.18 | 0.19 | 0.23 | 0.17 | 0.15 | 0.17 | 0.18 | |
| 0.14 | -48.01 | 0.08 | 2.09 | 1.59 | 0.33 | 0.19 | 0.06 | -4.09 | – | – | – | |
| 0.29 | 0.84 | 0.13 | -0.34 | -0.18 | 0.26 | 0.06 | -0.29 | 0.13 | -0.52 | 1.01 | -0.30 | |
| 0.90 | 0.97 | 1.20 | 1.11 | 0.90 | 1.08 | 1.11 | 1.81 | 1.11 | 0.79 | 1.44 | 0.64 | |
| -0.55 | 3.09 | -0.65 | -0.73 | -0.78 | -2.67 | 1.07 | -1.10 | -4.30 | -1.17 | -0.59 | -2.78 | |
| 1.97 | 1.98 | 2.47 | 1.98 | 1.97 | 1.97 | 1.97 | 2.47 | 1.70 | 1.36 | 1.18 | 1.22 | |
| -0.17 | -0.05 | -0.04 | -0.03 | 4.41 | 5.13 | 0.50 | -1.01 | 0.01 | -0.10 | 0.01 | -0.66 | |
| 0.12 | -12.78 | 0.07 | -0.50 | 4.09 | 1.75 | -2.10 | -1.36 | -2.36 | -1.15 | -0.56 | 0.73 | |
| -2.77 | -3.63 | -3.26 | -3.23 | -3.21 | -0.92 | -5.03 | -4.68 | 0.40 | -2.95 | -2.28 | -0.77 | |
| -0.62 | 0.75 | -0.45 | -0.51 | 0.24 | 0.37 | 0.21 | -0.89 | -0.19 | -0.36 | 0.26 | -0.10 | |
| 1.76 | 0.34 | 2.11 | 2.39 | 3.33 | 2.92 | 3.08 | 3.10 | 2.52 | 3.04 | 1.72 | 2.83 |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.